Greenfield plant provides needed insulin formulation and filling capacity

Involved in all engineering disciplines, NNE played an important role when Novo Nordisk established its second insulin plant in China.

Novo Nordisk has established its second insulin facility in Tianjin. The first packaging facility was built in 1996 and the first production facility in 2002 with an expansion in 2005. Major Novo Nordisk insulin products such as NovoMix® 30 and NovoRapid® are formulated and filled in the new plant.

Providing the full range of engineering expertise

The site covers 88,000 m2, the same as eight football fields. And the plant has a cold storage capacity equal to 21,000 large household refrigerators. If all the Penfill® units produced by the new plant in one year were to be placed end to end, they would cover the distance from Tianjin in China to the NNE HQ in Denmark and back again.

NNE’s technology experts ensured that the most advanced technology from the various Novo Nordisk sites worldwide was identified, improved, and implemented in the new facility. NNE was in charge of all engineering disciplines and more than 50 employees were involved. The majority of the project team were from NNE in China, alongside employees from our offices in Sweden, Germany and Denmark.

Since the start-up of the facility, NNE has continuously been employed for upgrade and expansion projects in the facility – including the completion and start-up of a second filling line.

Quick facts


Novo Nordisk (China) Pharmaceuticals, co, Ltd., China



Project duration

Aug. 2008 – Jun. 2013

Services provided

All engineering services